A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy

Introduction Combination therapy using immuno‐oncology drugs with tyrosine kinase inhibitors is increasingly important in the therapeutic strategy for metastatic renal cell carcinomas. Here, we report a case of metastatic renal cell carcinoma that was successfully treated with deferred cytoreductive...

詳細記述

書誌詳細

出版年:	IJU Case Reports
主要な著者:	Hiroaki Sato, Tomokazu Sazuka, Ayumi Fujimoto, Sakurako Kagitani, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Jun‐Ichiro Ikeda, Tomohiko Ichikawa
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2023-05-01
主題:	deferred cytoreductive nephrectomy immuno‐oncology therapy metastatic renal cell carcinoma tyrosine kinase inhibitor
オンライン･アクセス:	https://doi.org/10.1002/iju5.12584